Clinical trials
Phase 2 Heart Failure trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
378 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 10 |
| 2004 | 19 |
| 2005 | 9 |
| 2006 | 10 |
| 2007 | 11 |
| 2008 | 12 |
| 2009 | 20 |
| 2010 | 26 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 19 |
| 2014 | 13 |
| 2015 | 9 |
| 2016 | 19 |
| 2017 | 21 |
| 2018 | 14 |
| 2019 | 12 |
| 2020 | 13 |
| 2021 | 15 |
| 2022 | 16 |
| 2023 | 15 |
| 2024 | 21 |
| 2025 | 22 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 221 |
| Terminated | 52 |
| Unknown status | 34 |
| Recruiting | 33 |
| Withdrawn | 19 |
| Not yet recruiting | 9 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 15 |
| Novartis Pharmaceuticals | 9 |
| Cytokinetics | 8 |
| AstraZeneca | 7 |
| Bristol-Myers Squibb | 7 |
| Duke University | 7 |
| University of Aarhus | 7 |
| Virginia Commonwealth University | 6 |
| Cardurion Pharmaceuticals, Inc. | 5 |
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 378 |
| Cardiovascular Diseases | 21 |
| Inflammation | 12 |
| Cardiomyopathies | 11 |
| Diabetes Mellitus | 11 |
| Heart Diseases | 11 |
| Heart Failure, Diastolic | 11 |
| Myocardial Infarction | 11 |
| Renal Insufficiency | 11 |
| Cardiomyopathy, Dilated | 10 |
Trials
Showing 26 to 50 of 378. Each trial links to its page on Pharma Observatory.
278 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.